Impaired neutrophil function in intestinal lymphangiectasia.

Editor's note: Though this is an old article, I am including it in our database as it appears to be a one of a kind reference article.

J Clin Pathol. 1986 August; 39(8): 876–880.

Abstract

Impaired neutrophil chemotaxis and phagocytosis were shown in three patients with intestinal lymphangiectasia. Abnormalities in cell associated and serum derived activity occurred, and possible mechanisms are suggested.

Full Text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (649K), or see the PubMed citation or the full text of some References or click on a page below to browse page by page.

Scanned Article available

References:

Roberts SH, Douglas AP. Intestinal lymphangiectasia: the variability of presentation. A study of five cases. Q J Med. 1976 Jan;45(177):39–48. [PubMed]

Asakura H, Miura S, Morishita T, Aiso S, Tanaka T, Kitahora T, Tsuchiya M, Enomoto Y, Watanabe Y. Endoscopic and histopathological study on primary and secondary intestinal lymphangiectasia. Dig Dis Sci. 1981 Apr;26(4):312–320. [PubMed]

Weiden, Paul L.; Blaese, R Michael.; Strober, Warren.; Block, Jerome B.; Waldmann, Thomas A. Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man. J Clin Invest. 1972 Jun;51(6):1319–1325. [Free Full text in PMC]

Ward M, Le Roux A, Small WP, Sircus W. Malignant lymphoma and extensive viral wart formation in a patient with intestinal lymphangiectasia and lymphocyte depletion. Postgrad Med J. 1977 Dec;53(626):753–757. [PubMed]

Ross IN, Chesner I, Thompson RA, Parker RG, Asquith P. Cutaneous viral infection as a presentation of intestinal lymphangiectasia. Br J Dermatol. 1982 Sep;107(3):357–363. [PubMed]

HOLT PR. DIETARY TREATMENT OF PROTEIN LOSS IN INTESTINAL LYMPHANGIECTASIA. THE EFFECT OF ELIMINATING DIETARY LONG CHAIN TRIGLYCERIDES ON ALBUMIN METABOLISM IN THIS CONDITION. Pediatrics. 1964 Nov;34:629–635. [PubMed]

Wilkinson PC. Leukocyte locomotion and chemotaxis: effects of bacteria and viruses. Rev Infect Dis. 1980 2(2):293–318.Mar–Apr; [PubMed]

Hoffstein ST, Weissmann G, Pearlstein E. Fibonectin is a component of the surface coat of human neutrophils. J Cell Sci. 1981 Aug;50:315–327. [PubMed] [Free Full Text]

Christou NV, Meakins JL. Neutrophil function in anergic surgical patients: neutrophil adherence and chemotaxis. Ann Surg. 1979 Nov;190(5):557–564. [PubMed]

Anderson DC, Krishna GS, Hughes BJ, Mace ML, Mintz AA, Smith CW, Nichols BL. Impaired polymorphonuclear leukocyte motility in malnourished infants: relationship to functional abnormalities of cell adherence. J Lab Clin Med. 1983 Jun;101(6):881–895. [PubMed]

Schopfer K, Douglas SD. Neutrophil function in children with kwashiorkor. J Lab Clin Med. 1976 Sep;88(3):450–461. [PubMed]

Maderazo EG, Woronick CL. Quantitating functional capacity of mature and immature (nonsegmented) neutrophils. J Infect Dis. 1983 Apr;147(4):781. [PubMed]

Wyke RJ, Yousif-Kadaru AG, Rajkovic IA, Eddleston AL, Williams R. Serum stimulatory activity and polymorphonuclear leucocyte movement in patients with fulminant hepatic failure. Clin Exp Immunol. 1982 Nov;50(2):442–449. [PubMed]

Deitch EA, Gelder F, McDonald JC. The relationship between CIG depletion and peripheral neutrophil function in rabbits and man. J Trauma. 1982 Jun;22(6):469–475. [PubMed]

Pearlstein E, Gold LI, Garcia-Pardo A. Fibronectin: a review of its structure and biological activity. Mol Cell Biochem. 1980 Feb 8;29(2):103–128. [PubMed]

Elmgreen J. Subnormal activation of phagocytes by complement in chronic inflammatory bowel disease? Neutrophil chemotaxis to complement split product C5a. Gut. 1984 Jul;25(7):737–742. [PubMed]

Yousif-Kadaru AG, Rajkovic IA, Wyke RJ, Williams R. Defects in serum attractant activity in different types of chronic liver disease. Gut. 1984 Jan;25(1):79–84. [PubMed]

Rhodes JM, Potter BJ, Brown DJ, Jewell DP. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. Gastroenterology. 1982 Jun;82(6):1327–1334. [PubMed]

Van Epps DE, Strickland RG, Williams RC Jr. Inhibitors of leukocyte chemotaxis in alcoholic liver disease. Am J Med. 1975 Aug;59(2):200–207. [PubMed]

Maderazo EG, Ward PA, Woronick CL, Kubik J, DeGraff AC Jr. Leukotactic dystunction in sarcoidosis. Ann Intern Med. 1976 Apr;84(4):414–419. [PubMed]

Ward PA, Goralnick S, Bullock WE. Defective leukotaxis in patients with lepromatous leprosy. J Lab Clin Med. 1976 Jun;87(6):1025–1032. [PubMed]

Ward PA, Berenberg JL. Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator. N Engl J Med. 1974 Jan 10;290(2):76–80. [PubMed]

Foster PN, Bullen AW, Robertson DA, Chalmers DM, Losowsky MS. Development of impaired splenic function in intestinal lymphangiectasia. Gut. 1985 Aug;26(8):861–864. [PubMed]

Goetzl EJ. Plasma and cell-derived inhibitors of human neutrophil chemotaxis. Ann N Y Acad Sci. 1975 Jun 13;256:210–221. [PubMed]

Corazza GR, Bullen AW, Hall R, Robinson PJ, Losowsky MS. Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond). 1981 Jan;60(1):109–113. [PubMed]

Breedveld FC, Lafeber GJ, de Vries E, Leyh PC, Daha MR, Cats A. Fc receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome. Clin Exp Immunol. 1984 Mar;55(3):677–683. [PubMed]

Moore LL, Humbert JR. Neutrophil bactericidal dysfunction towards oxidant radical-sensitive microorganisms during experimental iron deficiency. Pediatr Res. 1984 Jul;18(7):684–689. [PubMed]

Czop JK, Austen KF. Augmentation of phagocytosis by a specific fibronectin fragment that links particulate activators to the fibronectin adherence receptor of human monocytes. J Immunol. 1982 Dec;129(6):2678–2681. [PubMed] [Full Text]

Fridkin M, Stabinsky Y, Zakuth V, Spirer Z. Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes. Biochim Biophys Acta. 1977 Jan 24;496(1):203–211. [PubMed]

Cooper MR, DeChatelet LR, Shirley PS, Cooper MR. Does tuftsin alter phagocytosis by human polymorphonuclear neutrophils? Inflammation. 1982 Mar;6(1):103–112. [PubMed]